Understanding Osteoporosis

Osteoporosis is a progressive condition where bone mineral density decreases, compromising skeletal strength and increasing fracture susceptibility. The World Health Organization defines it clinically as a T-score of −2.5 or lower on bone density imaging, reflecting a departure from healthy young adult bone mass.

The disease develops silently without symptoms until a fracture occurs. Even minor trauma—a fall from standing height or a bump—can cause significant breaks in compromised bones. This is why risk assessment matters: identifying vulnerable individuals allows for early intervention before fractures happen.

Two pathways lead to osteoporosis: primary osteoporosis stems from age-related bone loss and hormonal decline (especially post-menopausal estrogen deficiency in women), while secondary osteoporosis results from medical conditions, medications, or lifestyle factors that accelerate bone turnover.

Key Risk Factors and Contributors

Several modifiable and non-modifiable factors influence osteoporosis risk:

  • Age and sex: Bone density peaks in the early 30s and declines thereafter. Women lose bone rapidly in the decade following menopause due to oestrogen withdrawal.
  • Body weight: Lower body mass reduces skeletal loading and provides less mechanical stimulus for bone maintenance. Being significantly underweight is a documented risk factor.
  • Ethnicity: Caucasian and Asian populations have lower peak bone mass than African populations, translating to higher fracture risk at equivalent density levels.
  • Fracture history: Prior fragility fractures (breaks from minimal trauma) indicate bone quality issues beyond density alone.
  • Rheumatoid arthritis: Systemic inflammation and reduced mobility accelerate bone loss.
  • Chronic obstructive pulmonary disease: COPD correlates with increased fracture risk through systemic inflammation and reduced activity.
  • Lifestyle factors: Smoking impairs bone formation; excessive alcohol disrupts mineral absorption and balance; sedentary behaviour removes mechanical loading stimulus.

Osteoporosis Risk Scoring Methods

Three validated scoring systems quantify fracture risk based on clinical and demographic data. The OST applies universally; SCORE targets women; MORES adds COPD assessment for men.

OST = ((Weight in kg × 0.45359237) − Age in years) ÷ 5

SCORE = Ethnicity + Oestrogen therapy + Fractures + Rheumatoid arthritis + (3 × Age ÷ 10) − (Weight ÷ 10)

MORES = Age + Weight + COPD status (adjusted coefficients)

  • Weight — Body mass in kilograms (or converted from pounds); used as a proxy for skeletal loading and bone strength
  • Age — Age in completed years; accounts for cumulative bone loss over the lifespan
  • Ethnicity — Categorical factor reflecting baseline bone mass variation; contributes to SCORE only
  • Oestrogen therapy — History of hormone replacement therapy; protective factor in postmenopausal women
  • Fractures — Count of prior fragility fractures; indicator of underlying bone quality
  • Rheumatoid arthritis — Presence of RA diagnosis; inflammatory marker included in SCORE
  • COPD status — Chronic obstructive pulmonary disease presence; component of MORES for men

Practical Considerations and Pitfalls

Accurate risk assessment depends on reliable input data and understanding score limitations.

  1. Weight measurement timing — Use your current weight, not historical or target weight. Recent significant weight loss artificially elevates risk scores. If weight has fluctuated substantially, consider using an average of recent months for the most representative assessment.
  2. Score thresholds are not diagnostic — Risk scores estimate probability, not certainty. A high score warrants bone density imaging (DEXA) but does not diagnose osteoporosis. Conversely, a low score does not exclude the condition in someone with relevant symptoms or risk concentrations.
  3. Medication and supplement blind spots — This calculator does not capture all contributors: long-term glucocorticoid use, anticonvulsants, certain cancer therapies, and calcium/vitamin D deficiency all raise risk but are not explicitly scored. Report these to your clinician.
  4. Ethnicity and bone density variation — Ethnic-specific bone density references exist because peak bone mass and fracture risk differ across populations. The SCORE system uses ethnicity as a proxy, but individual variation is substantial—use results as one input, not the sole determinant.

Interpreting Your Results and Next Steps

OST Score interpretation:

  • Women: Score ≥1 indicates low risk; −3 to 1 is moderate risk; <−3 is high risk.
  • Men: Score ≥3 indicates low risk; −1 to 3 is moderate risk; <−1 is high risk.

SCORE (women): Low risk <7 points; moderate risk 7–12; high risk >12.

MORES (men): Follows similar stratification with COPD weighted as an additional contributor.

A high-risk result warrants formal bone density testing via dual-energy X-ray absorptiometry (DEXA scan). Even moderate-risk individuals over 65 (women) or 70 (men) should discuss screening with their GP. Low-risk individuals benefit from bone-protective lifestyle measures: weight-bearing exercise, adequate calcium and vitamin D intake, smoking cessation, and limited alcohol consumption.

Frequently Asked Questions

What is a T-score and how does it relate to osteoporosis?

A T-score compares your bone density to that of a healthy young adult, with the difference expressed in standard deviations. A T-score of −1.0 to −2.49 indicates osteopenia (low bone mass); −2.5 or lower defines osteoporosis. The lower the T-score, the weaker your bones and the higher your fracture risk. This calculator estimates who should undergo DEXA scanning to obtain an actual T-score.

Why is postmenopausal status so significant for osteoporosis risk in women?

Oestrogen is essential for bone maintenance; it inhibits bone-resorbing cells and promotes bone formation. At menopause, oestrogen levels plummet, triggering rapid bone loss—women can lose 1–3% of bone mass annually in the five years following menopause. Up to 30% of postmenopausal women eventually develop osteoporosis. This is why the SCORE and MORES systems explicitly account for oestrogen status and age relative to menopause.

Can osteoporosis be reversed or just managed?

True reversal of severe osteoporosis is rare, but progression can be halted and density improved with treatment. Bisphosphonates, denosumab, and other bone-modifying agents slow bone loss; some can modestly increase density. Prevention through early lifestyle intervention—exercise, nutrition, hormone preservation where appropriate—is far more effective than attempting to reverse advanced disease. Starting preventive measures in your 30s and 40s yields greater lifetime bone health than waiting until symptoms appear.

How often should I retest my bone density if my risk score is high?

Guidelines recommend baseline DEXA scanning for all women aged 65+ and men aged 70+, regardless of score. If high-risk features are present (prior fracture, long-term steroids, rheumatoid arthritis), earlier testing is justified. Repeat DEXA intervals typically span 1–2 years during treatment or in very high-risk individuals, and 3–5 years for stable, low-treatment cases. Your GP will recommend intervals based on your baseline results and response to interventions.

Does a low OST score mean I don't need to worry about bone health?

A low-risk score is reassuring but not a licence to ignore bone health. Risk scores capture population-level probabilities, not individual circumstances. Someone with a low score who smokes heavily, lacks exercise, consumes minimal calcium, or has undiagnosed coeliac disease may still develop osteoporosis. All adults should maintain bone-protective habits: regular weight-bearing activity, balanced nutrition with adequate calcium and vitamin D, alcohol moderation, and smoking cessation.

Should I start medication based solely on my risk calculator score?

No. Risk scores inform clinical decision-making but do not independently determine treatment. Your doctor will consider your score alongside DEXA results (if available), fracture history, age, sex, and other medical conditions. Many people with high risk scores benefit from lifestyle modification alone; others may warrant pharmacotherapy. Conversely, some with moderate scores may need medication if they have suffered a fragility fracture. Always discuss results with your GP before starting any bone-protective medication.

More health calculators (see all)